Collecting Recorded Videos of Colonoscopy
Launched by MAGENTIQ EYE LTD · Mar 23, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on testing a new device called the APDS during colonoscopy procedures. Colonoscopies are tests used to look inside the colon and can help detect growths called polyps, which may lead to cancer. The main goal of the study is to see how well the APDS device works in finding these polyps, and to explore the possibilities of a newer version of the device in the future.
To participate in this study, individuals need to be at least 18 years old and able to read and understand the information provided about the trial. However, those with certain health issues, like bleeding disorders or serious illnesses, cannot participate. If eligible, participants can expect to undergo a standard colonoscopy with the added evaluation of the APDS device. The study is currently recruiting, and everyone, regardless of gender, is welcome to apply.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Subjects must meet all the - criteria related to regular colonoscopy according to the standard of care at the Gastroenterology Department of the selected center, _In addition the following - criteria have to be met to be eligible for the study:
- • 1. Able to read, understand and provide written Informed Consent;
- • 2. Females or males - older than 18 years old
- Exclusion Criteria:
- Any of the following colonoscopy related exclusion criteria will exclude the subject from the study:
- • Bleeding disorder or unacceptable risk of bleeding
- • Terminal illness or life threatening malignancy
About Magentiq Eye Ltd
Magentiq Eye Ltd. is a pioneering clinical trial sponsor dedicated to advancing ocular health through innovative research and development. With a focus on harnessing cutting-edge technologies and methodologies, the company aims to improve treatment outcomes for patients with various eye conditions. By collaborating with leading experts and institutions, Magentiq Eye Ltd. is committed to conducting rigorous clinical trials that prioritize patient safety and efficacy, ultimately striving to bring transformative therapies to the ophthalmic market.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jerusalem, , Israel
Patients applied
Trial Officials
Harold Jacob, MD
Principal Investigator
Senior Gastroenterologist
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials